1,899
Views
14
CrossRef citations to date
0
Altmetric
Editorial

Nanomedicine and neurodegenerative disorders: so close yet so far

(Professor) , (Professor) , (Professor) & (Professor)

Bibliography

  • Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nat Rev Neurol 2011;7:137–52
  • Andrieux K, Couvreur P. Nanomedicine as a promising approach for the treatment and diagnosis of brain diseases: the example of Alzheimer’s disease. Ann Pharm Fr 2013;71:225–33
  • Ruozi B, Belletti D, Pederzoli F, et al. Nanotechnology and Alzheimer’s disease: what has been done and what to do. Curr Med Chem 2014;21:4169–85
  • Agrawal U, Chashoo G, Sharma PR, et al. Tailored polymer-lipid hybrid nanoparticles for the delivery of drug conjugate: Dual strategy for brain targeting. Colloids Surf B Biointerfaces 2015;126:414–25
  • Newton HB. Advances in strategies to improve drug delivery to brain tumors. Expert Rev Neurother 2006;6:1495–509
  • Zhang Y, Wang Z, Gemeinhart RA. Progress in microRNA delivery. J Control Rel 2013;172:962–74
  • Gabathuler R. Development of new peptide vectors for the transport of therapeutic across the blood-brain barrier. Ther Deliv 2010;1:571–86
  • Gabathuler R. Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases. Neurobiol Dis 2010;37:48–57
  • Niewoehner J, Bohrmann B, Collin L, et al. Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle. Neuron 2014;81:49–60
  • Tosi G, Bortot B, Ruozi B, et al. Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier. Curr Med Chem 2013;20:2212–25
  • Vilella A, Tosi G, Grabrucker AM, et al. Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution. J Control Rel 2014;174:195–201
  • Teli MK, Mutalik S, Rajanikant GK. Nanotechnology and nanomedicine: going small means aiming big. Curr Pharm Des 2010;16:1882–92
  • Pautler M, Brenner S. Nanomedicine: promises and challenges for the future of public health. Int J Nanomedicine 2010;5:803–9
  • Murday JS, Siegel RW, Stein J, et al. Translational nanomedicine: status assessment and opportunities. Nanomedicine 2009;5:251–73
  • Wagner V, Dullaart A, Bock AK, et al. The emerging nanomedicine landscape. Nature Biotech 2006;24:1211–17

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.